(Total Views: 160)
Posted On: 06/08/2018 9:58:54 AM
Post# of 26899
$AMBS Eltoprazine was originally developed by Solvay (now Abbvie) for aggression-related indications. The eltoprazine program was out-licensed to PsychoGenics, Inc. (PGI). PGI licensed eltoprazine to Amarantus in 2014 after a successful proof-of-concept trial in PD-LID.
https://finance.yahoo.com/news/amarantus-prov...46167.html
$AMBS
https://finance.yahoo.com/news/amarantus-prov...46167.html
$AMBS
(0)
(0)
Consider all my posts my opinion and not advice to buy or sell anything. I post on stocks I own or am considering owning. Do your own DD!
Scroll down for more posts ▼
